Strategent Financial’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$409K Sell
3,182
-132
-4% -$15.4K 0.24% 33
2026
Q1
$399K Sell
3,314
-161
-5% -$18.6K 0.27% 31
2025
Q4
$366K Hold
3,475
– – 0.23% 32
2025
Q3
$292K Hold
3,475
– – 0.21% 32
2025
Q2
$275K Hold
3,475
– – 0.21% 31
2025
Q1
$312K Sell
3,475
-125
-3% -$11.7K 0.28% 30
2024
Q4
$358K Buy
+3,600
New +$371K 0.36% 24

Other funds holding MRK

Strategent Financial's MRK Position: Q2 2026 in Review

Strategent Financial reduced its Merck (MRK) stake by 4% in Q2 2026, selling an estimated $15.4K and leaving 3,182 shares worth $409K. The position accounts for 0.24% of the portfolio, ranked #33.

Strategent Financial first reported a position in MRK in Q4 2024 and has held it in 7 quarters since. 3,852 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Strategent Financial held 3,182 shares of Merck worth $409K as of Q2 2026.
  • Strategent Financial sold 132 Merck shares in Q2 2026, an estimated $15.4K.
  • Merck made up 0.24% of Strategent Financial's portfolio in Q2 2026, its #33 holding.
  • Strategent Financial first reported a position in Merck in Q4 2024 and has held it in 7 quarters since.
  • 3,852 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Strategent Financial's 13F filing for Q2 2026, filed 3 Aug 2026.